ReviewPolymers2026
Meniscus Tissue Engineering Scaffolds: Biomaterials, Biofabrication, and Translation.
Review in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The meniscus is a fibrocartilaginous tissue essential for load transmission, shock absorption, joint stability, and cartilage protection in the knee. However, its intrinsic healing capacity is severely limited, particularly in the avascular region and in complex defects, often resulting in persistent symptoms, functional impairment, and progressive joint degeneration. Although current clinical interventions, including meniscal repair, partial meniscectomy, allograft transplantation, and scaffold-assisted meniscal substitution, can provide symptomatic and functional improvement in selected patients, durable structural and functional restoration remains difficult to achieve. Meniscus tissue engineering has therefore emerged as a potential strategy for tissue preservation and functional reconstruction. This review synthesizes recent advances in meniscus tissue-engineered scaffolds, focusing on biomaterial systems, biofabrication strategies, and translational progress. Natural polymers, decellularized extracellular matrix, synthetic polymers, and composite materials are discussed according to their respective roles in biological regulation, mechanical support, structural organization, and clinical feasibility. Emerging biofabrication strategies are further analyzed with respect to geometric reconstruction, zonal organization, fibrous anisotropy, and their implications for scaffold evaluation. Finally, current in vitro, preclinical, and clinical evidence is critically examined to identify the key barriers that still limit long-term regeneration and clinical translation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.